Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies (Q24235107)

From Wikidata

Jump to navigation Jump to search

scientific article (published 2011-11-09)

edit

Language	Label	Description	Also known as
English	Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies	scientific article (published 2011-11-09)

Statements

instance of

scholarly article

0 references

title

Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies (English)

0 references

main subject

Parkinson's disease

1 reference

based on heuristic

inferred from title

inflammation

0 references

author

Karen Rees

series ordinal

1

0 references

Rebecca Stowe

series ordinal

2

0 references

Natalie Ives

series ordinal

4

0 references

Smitaa Patel

0 references

Yoav Ben-Shlomo

series ordinal

7

0 references

Kieran C. Breen

object named as

Kieran Breen

series ordinal

5

0 references

Carl E Clarke

series ordinal

6

object named as

Carl E Clarke

0 references

publication date

9 November 2011

0 references

published in

Cochrane Database of Systematic Reviews

0 references

cites work

Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

Use of non-steroidal anti-inflammatory drugs and risk of Parkinson's disease: nested case-control study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

NSAID use and the risk of Parkinson's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

Use of ibuprofen and risk of Parkinson disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

Smoking, caffeine, and nonsteroidal anti-inflammatory drugs in families with Parkinson disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

Peripheral inflammatory biomarkers and risk of Parkinson's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

Cyclooxygenase-2 polymorphisms in Parkinson's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

Risk for Parkinson's disease among patients with osteoarthritis: a Danish cohort study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

Inflammatory cytokine gene polymorphisms and increased risk of Parkinson disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

Aspirin in Alzheimer's disease (AD2000): a randomised open-label trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

Cardiovascular and cerebrovascular events in the randomized, controlled Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

Randomized pilot study of nimesulide treatment in Alzheimer's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

Common anti-inflammatory drugs are potentially therapeutic for Parkinson's disease?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

Nonsteroidal anti-inflammatory drugs in experimental parkinsonian models and Parkinson's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

Aspirin and anti-inflammatory drugs for Alzheimer's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

Meta-analysis of nonsteroidal antiinflammatory drug use and risk of dementia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

Non-steroidal anti-inflammatory drugs in Parkinson's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

Neuroinflammation in Parkinson's disease: a target for neuroprotection?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

Therapeutic approaches to inflammation in neurodegenerative disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

The cardiovascular toxicity of selective and nonselective cyclooxygenase inhibitors: comparisons, contrasts, and aspirin confounding

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

Glial reactions in Parkinson's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

Meta-analysis: cardiovascular events associated with nonsteroidal anti-inflammatory drugs

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

No advantage of A beta 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

Indomethacin for the treatment of Alzheimer's disease patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

Ibuprofen for Alzheimer's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

What is the harm-benefit ratio of Cox-2 inhibitors?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

An inflammatory pathomechanism for Parkinson's disease?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

Inflammation as a causative factor in the aetiology of Parkinson's disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

21 January 2018

Acute exacerbation of Parkinson's disease with sulindac

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-steroidal anti-inflammatory drug use and the risk of Parkinson disease: A retrospective cohort study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug points: Exacerbation of idiopathic Parkinson's disease by naproxen

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunologic diseases, anti-inflammatory drugs, and Parkinson disease: a case-control study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD008454.PUB2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1002/14651858.CD008454.PUB2

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

4556641

OpenCitations bibliographic resource ID

4556641

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

4556641

PubMed publication ID

22071848

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

4556641

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24235107&oldid=1856798875"